Engaging with HCV reinfection to advance microelimination.

Garvey, Lucy; Cooke, Graham S

Garvey, Lucy; Cooke, Graham S.

Garvey L; Imperial College NHS Trust, London, UK; NIHR Biomedical Research Centre, Imperial College NHS Trust, St Mary's Hospital, London, UK.
Cooke GS; Imperial College NHS Trust, London, UK; NIHR Biomedical Research Centre, Imperial College NHS Trust, St Mary's Hospital, London, UK; Department of Infectious Disease, Imperial College London, London W2 1NY, UK. Electronic address: g.cooke@imperial.ac.uk.

Lancet HIV ; 9(6): e372-e374, 2022 06.

Article in English | MEDLINE | ID: covidwho-1895527

Subject(s)

HIV Infections; Hepatitis C; Substance Abuse, Intravenous; Antiviral Agents/therapeutic use; HIV Infections/drug therapy; Hepacivirus/genetics; Hepatitis C/epidemiology; Hepatitis C/prevention & control; Humans; Reinfection; Substance Abuse, Intravenous/drug therapy; Sustained Virologic Response

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Substance Abuse, Intravenous / Hepatitis C Type of study: Observational study Limits: Humans Language: English Journal: Lancet HIV Year: 2022 Document Type: Article Affiliation country: S2352-3018(22)00128-X

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google